XtalPi Holdings Limited (QNTPF)

Market Cap	6.26B +220.8%
Revenue (ttm)	95.04M +245.5%
Net Income	-27.47M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	485
Average Volume	2,315
Open	1.610
Previous Close	n/a
Day's Range	1.610 - 1.610
52-Week Range	0.600 - 2.040
Beta	n/a
RSI	49.17
Earnings Date	Mar 30, 2026

About XtalPi Holdings

XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicoch...

• Industry: Commercial Physical and Biological Research
• Founded: 2015
• Employees: 1,054
• Stock Exchange: OTCMKTS
• Ticker Symbol: QNTPF

Financial Performance

In 2024, XtalPi Holdings's revenue was 266.43 million, an increase of 52.75% compared to the previous year's 174.42 million. Losses were -1.52 billion, -20.78% less than in 2023.

Financial numbers in CNY